Isolation of CD4+CD25+ regulatory T cells for clinical trials

Biology of Blood and Marrow Transplantation

Volumn 12, Issue 3, 2006, Pages 267-274

  Hoffmann, Petra ^a,c   Boeld, Tina J ^a   Eder, Ruediger ^a   Albrecht, Julia ^a   Doser, Kristina ^a   Piseshka, Biserka ^a   Dada, Ashraf ^a   Niemand, Claudia ^b   Assenmacher, Mario ^b   Orsó, Evelyn ^a   Andreesen, Reinhard ^a   Holler, Ernst ^a   Edinger, Matthias ^a  

^a UNIVERSITY HOSPITAL REGENSBURG   (Germany)

^b MILTENYI BIOTEC GMBH   (Germany)

^c UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

Anergy; Good manufacturing practice; Graft versus host disease; Suppressor T lymphocytes; Tolerance

Indexed keywords

TRANSCRIPTION FACTOR FOXP3;

ADOPTIVE IMMUNOTHERAPY; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; CD4+ CD25+ T LYMPHOCYTE; CELL FUNCTION; CELL ISOLATION; CELL PROLIFERATION; CELL SEPARATION; CELL TRANSFER; CELLULAR IMMUNITY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FATALITY; FLOW CYTOMETRY; FLUORESCENCE ACTIVATED CELL SORTING; GOOD MANUFACTURING PRACTICE; GRAFT VERSUS HOST REACTION; HUMAN; LEUKAPHERESIS; LYMPHOCYTE SUBPOPULATION; NONHUMAN; PHENOTYPE; PRACTICE GUIDELINE; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; RISK REDUCTION; WESTERN BLOTTING;

ADOPTIVE TRANSFER; ANIMALS; BONE MARROW TRANSPLANTATION; CLINICAL TRIALS; DISEASE MODELS, ANIMAL; FLOW CYTOMETRY; GRAFT VS HOST DISEASE; GUIDELINES; HUMANS; LEUKAPHERESIS; MICE; T-LYMPHOCYTES, REGULATORY; TRANSPLANTATION, HOMOLOGOUS;

EID: 33244455884     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2006.01.005     Document Type: Article

References (24)

1. P. Hoffmann J. Ermann M. Edinger C.G. Fathman S. Strober Donor-type CD4(+)CD25(+) regulatory T cells suppress lethal acute graft-versus-host disease after allogeneic bone marrow transplantation J Exp Med 196 2002 389-399
2. P.A. Taylor C.J. Lees B.R. Blazar The infusion of ex vivo activated and expanded CD4(+)CD25(+) immune regulatory cells inhibits graft-versus-host disease lethality Blood 99 2002 3493-3499
3. J.L. Cohen A. Trenado D. Vasey D. Klatzmann B.L. Salomon CD4(+)CD25(+) immunoregulatory T Cells: New therapeutics for graft-versus-host disease J Exp Med 196 2002 401-406
4. M. Edinger P. Hoffmann J. Ermann et al. CD4(+)CD25(+) regulatory T cells preserve graft-versus-tumor activity while inhibiting graft-versus-host disease after bone marrow transplantation Nat Med 9 2003 1144-1150
5. J. Ermann P. Hoffmann M. Edinger S. Dutt F.G. Blankenberg J.P. Higgins et al. Only the CD62L+ subpopulation of CD4+CD25+ regulatory T cells protects from lethal acute GVHD Blood 105 2005 2220-2226
6. S.C. Jones G.F. Murphy R. Korngold Post-hematopoietic cell transplantation control of graft-versus-host disease by donor CD4(+)25(+) T cells to allow an effective graft-versus-leukemia response Biol Blood Marrow Transplant 9 2003 243-256
7. C. Baecher-Allan J.A. Brown G.J. Freeman D.A. Hafler CD4+CD25high regulatory cells in human peripheral blood J Immunol 167 2001 1245-1253
8. D. Dieckmann H. Plottner S. Berchtold T. Berger G. Schuler Ex vivo isolation and characterization of CD4(+)CD25(+) T cells with regulatory properties from human blood J Exp Med 193 2001 1303-1310
9. H. Jonuleit E. Schmitt M. Stassen A. Tuettenberg J. Knop A.H. Enk Identification and functional characterization of human CD4(+)CD25(+) T cells with regulatory properties isolated from peripheral blood J Exp Med 193 2001 1285-1294
10. L.S. Taams J. Smith M.H. Rustin M. Salmon L.W. Poulter A.N. Akbar Human anergic/suppressive CD4(+)CD25(+) T cells: A highly differentiated and apoptosis-prone population Eur J Immunol 31 2001 1122-1131
11. M.K. Levings R. Sangregorio M.G. Roncarolo Human CD25(+)CD4(+) T regulatory cells suppress naive and memory T cell proliferation and can be expanded in vitro without loss of function J Exp Med 193 2001 1295-1302
12. W.F. Ng P.J. Duggan F. Ponchel et al. Human CD4(+)CD25(+) cells: A naturally occurring population of regulatory T cells Blood 98 2001 2736-2744
13. F. Annunziato L. Cosmi F. Liotta et al. Phenotype, localization, and mechanism of suppression of CD4(+)CD25(+) human thymocytes J Exp Med 196 2002 379-387
14. S. Hori T. Nomura S. Sakaguchi Control of regulatory T cell development by the transcription factor Foxp3 Science 299 2003 1057-1061
15. M.R. Walker D.J. Kasprowicz V.H. Gersuk et al. Induction of FoxP3 and acquisition of T regulatory activity by stimulated human CD4+CD25- T cells J Clin Invest 112 2003 1437-1443
16. J.D. Fontenot M.A. Gavin A.Y. Rudensky Foxp3 programs the development and function of CD4+CD25+ regulatory T cells Nat Immunol 4 2003 330-336
17. C. Baecher-Allan V. Viglietta D.A. Hafler Human CD4+CD25+ regulatory T cells Semin Immunol 16 2004 89-98
18. P. Hoffmann R. Eder L.A. Kunz-Schughart R. Andreesen M. Edinger Large-scale in vitro expansion of polyclonal human CD4(+)CD25high regulatory T cells Blood 104 2004 895-903
19. S. Sakaguchi Naturally arising CD4+ regulatory T cells for immunologic self-tolerance and negative control of immune responses Annu Rev Immunol 22 2004 531-562
20. B.D. Johnson E.E. Becker J.L. LaBelle R.L. Truitt Role of immunoregulatory donor T cells in suppression of graft-versus-host disease following donor leukocyte infusion therapy J Immunol 163 1999 6479-6487
21. Y. Miura C.J. Thoburn E.C. Bright et al. Association of Foxp3 regulatory gene expression with graft-versus-host disease Blood 104 2004 2187-2193
22. A. Trenado F. Charlotte S. Fisson et al. Recipient-type specific CD4+CD25+ regulatory T cells favor immune reconstitution and control graft-versus-host disease while maintaining graft-versus-leukemia J Clin Invest 112 2003 1688-1696
23. D.J. Powell Jr L.L. Parker S.A. Rosenberg Large-scale depletion of CD25+ regulatory T cells from patient leukapheresis samples J Immunother 28 2005 403-411
24. R.S. Wildin S. Smyk-Pearson A.H. Filipovich Clinical and molecular features of the immunodysregulation, polyendocrinopathy, enteropathy, X linked (IPEX) syndrome J Med Genet 39 2002 537-545